When must amino acid sequences be set forth separately in a patent application?
According to the MPEP, amino acid sequences must be set forth separately under certain conditions. Specifically: “When the coding parts of a nucleotide sequence and their corresponding amino acids have been enumerated by their residues, those amino acids must also be set forth as a separate sequence if the amino acid sequence meets the length…
Read MoreHow are codons that span introns represented in sequence listings?
The MPEP addresses the representation of codons that span introns in 37 CFR 1.822(c)(3). Specifically, it states: “In those situations, the ‘amino acid symbol shall be listed below the portion of the codon containing two nucleotides.’” This requirement clarifies how to represent an amino acid corresponding to a codon that spans an intron. It ensures…
Read MoreIs it mandatory to depict coding regions in patent applications?
No, it is not mandatory to depict coding regions in patent applications. The MPEP clearly states: “There is absolutely no requirement in the rules to depict coding regions.” However, if an applicant chooses to depict coding regions, they must follow the guidelines set forth in 37 CFR 1.822(c)(3). This includes listing the amino acids corresponding…
Read MoreHow should coding regions be depicted in patent applications?
According to 37 CFR 1.822(c)(3), if an applicant chooses to depict coding regions, the amino acids corresponding to the codons in the coding parts of a nucleotide sequence must be listed immediately below the corresponding codons. The MPEP states: “If applicant chooses to depict coding regions, 37 CFR 1.822(c)(3) requires the amino acids corresponding to…
Read More